2020
Kratom and Pain Tolerance: A Randomized, Placebo-Controlled, Double-Blind Study.
Vicknasingam B, Chooi WT, Rahim AA, Ramachandram D, Singh D, Ramanathan S, Yusof NSM, Zainal H, Murugaiyah V, Gueorguieva R, Mansor SM, Chawarski MC. Kratom and Pain Tolerance: A Randomized, Placebo-Controlled, Double-Blind Study. The Yale Journal Of Biology And Medicine 2020, 93: 229-238. PMID: 32607084, PMCID: PMC7309661.Peer-Reviewed Original ResearchConceptsDouble-blind studyPain toleranceCold pressor taskConsumption of placeboSigns of withdrawalKratom consumptionTraditional medicine useKratom ingestionPain reliefPain onsetInpatient staySafety profileMedicine useWithdrawal symptomsPlacebo drinkHand withdrawalHealth statusVital signsKratom productsSelf-reported dataRandomized sequencePlaceboKratomSignificant increaseDecoction
2003
Cluster Analysis Classification of SF-36 Profiles for Patients With Spinal Pain
Fanciullo GJ, Hanscom B, Weinstein JN, Chawarski MC, Jamison RN, Baird JC. Cluster Analysis Classification of SF-36 Profiles for Patients With Spinal Pain. Spine 2003, 28: 2276-2282. PMID: 14520044, DOI: 10.1097/01.brs.0000084880.33281.eb.Peer-Reviewed Original ResearchMeSH KeywordsCluster AnalysisFemaleHealth Status IndicatorsHumansMaleMiddle AgedPainPain MeasurementSpinal DiseasesConceptsChronic pain patientsPain patientsSpinal painSpine patientsSF-36Diagnostic categoriesNational Spine Network databaseSF-36 Health SurveySelf-reported health statusProportion of patientsChronic pain syndromeCommon diagnostic categoriesSF-36 Health Survey scalesClinical diagnosis groupHealth status dataSF-36 profilesRadicular painSpondylosis patientsPain syndromeDisc patientsInitial visitAppropriate therapyChronic painSpinal stenosisLife scores